GUD.TO vs. NVDA.TO

Last updated Jun 4, 2026

GUD.TO (Knight Therapeutics Inc.) and NVDA.TO (Nvidia CDR (CAD Hedged)) are both stocks. GUD.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare), while NVDA.TO operates in Semiconductors (Technology). Over the past 3 years, GUD.TO returned 19.42%/yr vs 72.52%/yr for NVDA.TO. At a 0.16 correlation, their price movements are largely independent.

Performance

GUD.TO vs. NVDA.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Knight Therapeutics Inc. (GUD.TO) and Nvidia CDR (CAD Hedged) (NVDA.TO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GUD.TO achieves a 37.36% return, which is significantly higher than NVDA.TO's 14.32% return.

GUD.TO

• 1D: 1.34%
• 1M: 10.07%
• YTD: 37.36%
• 6M: 37.58%
• 1Y: 43.28%
• 3Y*: 19.42%
• 5Y*: 9.58%
• 10Y*: -0.35%

NVDA.TO

• 1D: -3.51%
• 1M: 8.02%
• YTD: 14.32%
• 6M: 18.33%
• 1Y: 48.72%
• 3Y*: 72.52%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GUD.TO vs. NVDA.TO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
GUD.TO Knight Therapeutics Inc.	37.36%	13.30%	2.89%	0.19%	-2.26%
NVDA.TO Nvidia CDR (CAD Hedged)	14.32%	34.82%	167.13%	233.70%	-37.69%

Correlation

The correlation between GUD.TO and NVDA.TO is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (All Time) Calculated using the full available price history since Jan 27, 2022	0.16

The correlation between GUD.TO and NVDA.TO shifts across timeframes, from 0.05 (1 year) to 0.16 (all time), reflecting how their relationship changes across market environments.

Return for Risk

GUD.TO vs. NVDA.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GUD.TO

GUD.TO Risk / Return Rank: 85
GUD.TO Sharpe Ratio Rank: 86
GUD.TO Sortino Ratio Rank: 89
GUD.TO Omega Ratio Rank: 85
GUD.TO Calmar Ratio Rank: 86
GUD.TO Martin Ratio Rank: 81

NVDA.TO

NVDA.TO Risk / Return Rank: 77
NVDA.TO Sharpe Ratio Rank: 81
NVDA.TO Sortino Ratio Rank: 77
NVDA.TO Omega Ratio Rank: 73
NVDA.TO Calmar Ratio Rank: 77
NVDA.TO Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GUD.TO vs. NVDA.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Knight Therapeutics Inc. (GUD.TO) and Nvidia CDR (CAD Hedged) (NVDA.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GUD.TO	NVDA.TO	Difference
Sharpe ratio: Return per unit of total volatility	1.81	1.49	+0.32
Sortino ratio: Return per unit of downside risk	3.16	2.12	+1.04
Omega ratio: Gain probability vs. loss probability	1.35	1.25	+0.10
Calmar ratio: Return relative to maximum drawdown	3.60	2.33	+1.27
Martin ratio: Return relative to average drawdown	6.88	5.63	+1.26
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GUD.TO vs. NVDA.TO - Sharpe Ratio Comparison

The current GUD.TO Sharpe Ratio is 1.81, which is comparable to the NVDA.TO Sharpe Ratio of 1.49. The chart below compares the historical Sharpe Ratios of GUD.TO and NVDA.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GUD.TO	NVDA.TO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.81	1.49	+0.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.40	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.01	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.24	1.24	-1.00

Drawdowns

GUD.TO vs. NVDA.TO - Drawdown Comparison

The maximum GUD.TO drawdown since its inception was -60.09%, roughly equal to the maximum NVDA.TO drawdown of -61.15%. Use the drawdown chart below to compare losses from any high point for GUD.TO and NVDA.TO.

Drawdown Indicators

	GUD.TO	NVDA.TO	Difference
Max Drawdown Largest peak-to-trough decline	-60.09%	-61.15%	+1.06%
Max Drawdown (1Y) Largest decline over 1 year	-12.08%	-21.05%	+8.97%
Max Drawdown (3Y) Largest decline over 3 years	-17.58%	-37.49%	+19.91%
Max Drawdown (5Y) Largest decline over 5 years	-29.61%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-60.09%	—	—
Current Drawdown Current decline from peak	-23.76%	-8.77%	-14.99%
Average Drawdown Average peak-to-trough decline	-34.49%	-15.32%	-19.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.31%	8.69%	-2.38%

Volatility

GUD.TO vs. NVDA.TO - Volatility Comparison

Knight Therapeutics Inc. (GUD.TO) has a higher volatility of 13.15% compared to Nvidia CDR (CAD Hedged) (NVDA.TO) at 12.46%. This indicates that GUD.TO's price experiences larger fluctuations and is considered to be riskier than NVDA.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GUD.TO	NVDA.TO	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.15%	12.46%	+0.69%
Volatility (6M) Calculated over the trailing 6-month period	19.93%	24.90%	-4.97%
Volatility (1Y) Calculated over the trailing 1-year period	24.01%	32.87%	-8.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.04%	51.67%	-27.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.08%	51.67%	-27.59%

Dividends

GUD.TO vs. NVDA.TO - Dividend Comparison

GUD.TO has not paid dividends to shareholders, while NVDA.TO's dividend yield for the trailing twelve months is around 0.02%.

Position	TTM	2025	2024	2023	2022
GUD.TO Knight Therapeutics Inc.	0.00%	0.00%	0.00%	0.00%	0.00%
NVDA.TO Nvidia CDR (CAD Hedged)	0.02%	0.02%	0.02%	0.03%	0.11%

Financials

Frequently Asked Questions

Can I hold both GUD.TO and NVDA.TO in my portfolio?

GUD.TO and NVDA.TO have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.